• Je něco špatně v tomto záznamu ?

Evidence of necroptosis in hearts subjected to various forms of ischemic insults

A. Adameova, J. Hrdlicka, A. Szobi, V. Farkasova, K. Kopaskova, M. Murarikova, J. Neckar, F. Kolar, T. Ravingerova, NS. Dhalla,

. 2017 ; 95 (10) : 1163-1169. [pub] 20170504

Jazyk angličtina Země Kanada

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc18010598

Grantová podpora
NV15-27735A MZ0 CEP - Centrální evidence projektů

Long-lasting ischemia can result in cell loss; however, repeated episodes of brief ischemia increase the resistance of the heart against deleterious effects of subsequent prolonged ischemic insult and promote cell survival. Traditionally, it is believed that the supply of blood to the ischemic heart is associated with release of cytokines, activation of inflammatory response, and induction of necrotic cell death. In the past few years, this paradigm of passive necrosis as an uncontrolled cell death has been re-examined and the existence of a strictly regulated form of necrotic cell death, necroptosis, has been documented. This controlled cell death modality, resembling all morphological features of necrosis, has been investigated in different types of ischemia-associated heart injuries. The process of necroptosis has been found to be dependent on the activation of RIP1-RIP3-MLKL axis, which induces changes leading to the rupture of cell membrane. This pathway is activated by TNF-α, which has also been implicated in the cardioprotective signaling pathway of ischemic preconditioning. Thus, this review is intended to describe the TNF-α-mediated signaling leading to either cell survival or necroptotic cell death. In addition, some experimental data suggesting a link between heart dysfunction and the cellular loss due to necroptosis are discussed in various conditions of myocardial ischemia.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18010598
003      
CZ-PrNML
005      
20180417093709.0
007      
ta
008      
180404s2017 xxc f 000 0|eng||
009      
AR
024    7_
$a 10.1139/cjpp-2016-0609 $2 doi
035    __
$a (PubMed)28472590
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxc
100    1_
$a Adameova, Adriana $u a Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University in Bratislava, Slovak Republic.
245    10
$a Evidence of necroptosis in hearts subjected to various forms of ischemic insults / $c A. Adameova, J. Hrdlicka, A. Szobi, V. Farkasova, K. Kopaskova, M. Murarikova, J. Neckar, F. Kolar, T. Ravingerova, NS. Dhalla,
520    9_
$a Long-lasting ischemia can result in cell loss; however, repeated episodes of brief ischemia increase the resistance of the heart against deleterious effects of subsequent prolonged ischemic insult and promote cell survival. Traditionally, it is believed that the supply of blood to the ischemic heart is associated with release of cytokines, activation of inflammatory response, and induction of necrotic cell death. In the past few years, this paradigm of passive necrosis as an uncontrolled cell death has been re-examined and the existence of a strictly regulated form of necrotic cell death, necroptosis, has been documented. This controlled cell death modality, resembling all morphological features of necrosis, has been investigated in different types of ischemia-associated heart injuries. The process of necroptosis has been found to be dependent on the activation of RIP1-RIP3-MLKL axis, which induces changes leading to the rupture of cell membrane. This pathway is activated by TNF-α, which has also been implicated in the cardioprotective signaling pathway of ischemic preconditioning. Thus, this review is intended to describe the TNF-α-mediated signaling leading to either cell survival or necroptotic cell death. In addition, some experimental data suggesting a link between heart dysfunction and the cellular loss due to necroptosis are discussed in various conditions of myocardial ischemia.
650    _2
$a zvířata $7 D000818
650    12
$a apoptóza $x účinky léků $7 D017209
650    _2
$a lidé $7 D006801
650    _2
$a ischemická choroba srdeční $x metabolismus $x patologie $7 D017202
650    _2
$a myokard $x metabolismus $x patologie $7 D009206
650    _2
$a nekróza $7 D009336
650    _2
$a komplex proteinů jaderného póru $x metabolismus $7 D028861
650    _2
$a proteinkinasy $x metabolismus $7 D011494
650    _2
$a proteiny vázající RNA $x metabolismus $7 D016601
650    _2
$a serin-threoninkinasy interagující s receptory $x metabolismus $7 D053422
650    _2
$a signální transdukce $7 D015398
650    _2
$a TNF-alfa $x metabolismus $7 D014409
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Hrdlicka, Jaroslav $u b Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic.
700    1_
$a Szobi, Adrian $u a Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University in Bratislava, Slovak Republic.
700    1_
$a Farkasova, Veronika $u c Institute for Heart Research, Slovak Academy of Sciences and Centre of Excellence, SAS NOREG, Bratislava, Slovak Republic.
700    1_
$a Kopaskova, Katarina $u a Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University in Bratislava, Slovak Republic.
700    1_
$a Murarikova, Martina $u c Institute for Heart Research, Slovak Academy of Sciences and Centre of Excellence, SAS NOREG, Bratislava, Slovak Republic.
700    1_
$a Neckar, Jan $u b Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic.
700    1_
$a Kolar, Frantisek $u b Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic.
700    1_
$a Ravingerova, Tatiana $u c Institute for Heart Research, Slovak Academy of Sciences and Centre of Excellence, SAS NOREG, Bratislava, Slovak Republic.
700    1_
$a Dhalla, Naranjan S $u d Institute of Cardiovascular Sciences, St. Boniface Hospital Albrechtsen Research Centre, Winnipeg, MB R2H 2A6, Canada.
773    0_
$w MED00001020 $t Canadian journal of physiology and pharmacology $x 1205-7541 $g Roč. 95, č. 10 (2017), s. 1163-1169
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28472590 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180404 $b ABA008
991    __
$a 20180417093807 $b ABA008
999    __
$a ok $b bmc $g 1288083 $s 1007410
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 95 $c 10 $d 1163-1169 $e 20170504 $i 1205-7541 $m Canadian journal of physiology and pharmacology $n Can J Physiol Pharmacol $x MED00001020
GRA    __
$a NV15-27735A $p MZ0
LZP    __
$a Pubmed-20180404

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...